Preliminary experience with 15(S)15-methyl prostaglandin F2α for midtrimester abortion

This publication has 8 references indexed in Scilit:

• Midtrimester Abortion Using Prostaglandin F2α, Oxytocin, and Laminaria**Supported by The Upjohn Company, Kalamazoo, Michigan.††Presented at the Twenty-Ninth Annual Meeting of The American Fertility Society, April 5–7, 1973, San Francisco, California.
  Fertility and Sterility, 1973
• Intra-amniotic prostaglandin administration — A challenge to the currently used methods for induction of midtrimester abortion
  Contraception, 1973
• Midtrimester abortion produced by intra-amniotic prostaglandin F2α augmented with intravenous oxytoxin
  American Journal of Obstetrics and Gynecology, 1972
• TERMINATION OF SECOND TRIMESTER PREGNANCY WITH 15 METHYL ANALOGUES OF PROSTAGLANDINS E₂, AND F_2x
  BJOG: An International Journal of Obstetrics and Gynaecology, 1972
• FURTHER STUDIES ON THE INTERACTION BETWEEN PROSTAGLANDINS AND SYNTOCINON ON THE ISOLATED PREGNANT HUMAN MYOMETRIUM
  BJOG: An International Journal of Obstetrics and Gynaecology, 1972
• First trimester abortions induced by a single extraovular injection of prostaglandin F2α
  Prostaglandins, 1972
• Activity of 15[S]15-Methyl prostaglandin E2 and F2α as stimulants of uterine contractility
  Prostaglandins, 1972
• NOVEL PROSTAGLANDIN SYNTHESES
  Annals of the New York Academy of Sciences, 1971